glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Glutathione metabolism in cancer progression
Glutathione metabolism in cancer progression and treatment resistance PMC Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword Salidroside sensitizes Triple negative breast cancer to ferroptosis by SCD1 mediated lipogenesis and NCOA4 mediated ferritinophagy ScienceDirect Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



